Dietary Isoflavones and Intestinal Microbiota: Metabolism and Transformation into Bioactive Compounds
Capitolo di libro
Data di Pubblicazione:
2010
Citazione:
Dietary Isoflavones and Intestinal Microbiota: Metabolism and Transformation into Bioactive Compounds / Rossi, M., Amaretti, A., Roncaglia, L., Leonardi, A., Raimondi, S. - In: Isoflavones: Biosynthesis, Occurrence and Health Effects / Melanie J. Thompson. - STAMPA. - 400 OSER AVE, STE 1600, HAUPPAUGE, NY 11788-3635 USA : Melanie J. Thompson, 2010. - ISBN 9781612090665. - pp. 137-161
Abstract:
Edible plants provide the human with hundreds of non-nutritional phytochemicals which are recognized as beneficial, such as isoflavones. Likewise other polyphenols, isoflavones may undergo extensive transformations during passage through human digestive tract, especially in the colon, where members of the complex commensal microbiota are capable to carry out synergistically a broad range of metabolic transformations affecting the fate and the biological activity of phytochemicals. Diverse bacterial species occurring in the large intestine hydrolyze the glucose conjugated forms of isoflavones, releasing the corresponding aglycones, which may undergo further microbial conversions (especially reductions) giving rise to a wide spectrum of isoflavone-derived compounds. The end-products of microbial transformations are subjected to substantial person-to-person variation, reflecting the impact of the colonic microbiota, since intestinal bacteria may greatly increase or compromise the biological activity of dietary isoflavones. In fact, certain reduction products (e.g. S-equol) possess superior antioxidant and estrogen-like activities, while others are precursors for C-ring cleavage and lead to isoflavone degradation. Extensive research has been performed to characterize the intestinal bacteria which are responsible for isoflavones transformations. In particular, many efforts are being carried out to identify single bacteria that convert the major soy isoflavone daidzein into S-equol, in the perspective to enrich soy products with such a valuable isoflavone-derived metabolite. Besides, diverse bacteria which are capable of deglycosylation, demethylation, and various reduction reactions are increasingly being identified. Nonetheless, only bifidobacteria and lactobacilli, which produce β-glucosidase that hydrolyze isoflavone glycosides into the corresponding aglycones, are currently exploited to improve the biological activity of soymilk.
Tipologia CRIS:
Capitolo/Saggio
Keywords:
isoflavones; intestinal microbiota; biotransformation
Elenco autori:
Rossi, Maddalena; Amaretti, Alberto; Roncaglia, Lucia; Leonardi, Alan; Raimondi, Stefano
Link alla scheda completa:
Link al Full Text:
Titolo del libro:
Isoflavones: Biosynthesis, Occurrence and Health Effects